Perindopril significantly reduced aortic calcification (172 vs. 406 μmol/g, P<0.001) and improved indices of aortic stiffness in the LPK rat model of cystic renal disease.
Does perindopril improve pulse-wave velocity and aortic calcification in a rat model of cystic renal disease?
ACE inhibition with perindopril limits vascular remodeling, aortic stiffness, and calcification in a rat model of chronic kidney disease.
Absolute Event Rate: 172% vs 406%
p-value: p=<0.001
The effect of angiotensin-converting enzyme inhibition on function and structure of the aorta was studied in the Lewis polycystic kidney (LPK) rat model of cystic renal disease and Lewis controls. Pulse-wave velocity (PWV) was recorded under urethane anesthesia (1.3 g/kg ip) in mixed-sex animals aged 6 and 12 wk and in 12-wk-old animals treated with perindopril (3 mg·kg(-1)·day(-1) po) from age 6-12 wk. Tail-cuff systolic pressures were recorded over the treatment period. After PWV measurements, animals were euthanized and the aorta was removed for histomorphological and calcium analysis. Hypertension in LPK at 6 and 12 wk was associated with a shift of the PWV curve upward and to the right, indicating a decrease in aortic compliance, which was significantly reduced by perindopril. LPK demonstrated greater aortic calcification (6 wk: 123 ± 19 vs. 65 ± 7 and 12 wk: 406 ± 6 vs. 67 ± 6 μmol/g, P < 0.001, LPK vs. Lewis, respectively). This was reduced by treatment with perindopril (172 ± 48 μmol/g, 12 wk LPK P < 0.001). Medial cross-sectional area and elastic modulus/wall stress of the aorta were greater in LPK vs. Lewis control animals at 6 and 12 wk of age and showed an age-related increase that was prevented by treatment with perindopril (P < 0.001). Perindopril also ameliorated the degradation of elastin, increase in collagen content, and medial elastocalcinosis seen in 12-wk LPK. Overall, perindopril improved the structural and functional indices of aortic stiffness in the LPK rats, demonstrating a capacity for angiotensin-converting enzyme inhibition to limit vascular remodeling in chronic kidney disease.
Ng et al. (Thu,) conducted a other in Cystic renal disease. Perindopril vs. Untreated LPK rats was evaluated on Aortic calcification at 12 weeks (p=<0.001). Perindopril significantly reduced aortic calcification (172 vs. 406 μmol/g, P<0.001) and improved indices of aortic stiffness in the LPK rat model of cystic renal disease.